Skip to main content
Clinical Trials/NCT02463669
NCT02463669
Terminated
Not Applicable

The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department

Jewish General Hospital2 sites in 1 country200 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infectious Mononucleosis
Sponsor
Jewish General Hospital
Enrollment
200
Locations
2
Primary Endpoint
Presence of splenomegaly (maximal splenic cranio-caudal length) on point-of-care ultrasound
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine if splenomegaly on point-of-care ultrasound (POCUS) is an accurate and user-friendly surrogate to the heterophile antibody test and Epstein-Barr Virus (EBV) serologies to diagnose acute mononucleosis infection in patients presenting with sore throat to the Emergency Department (ED).

Detailed Description

The investigators seek to determine whether the presence of splenomegaly on POCUS can accurately diagnose acute infectious mononucleosis in symptomatic ED patients, and determine the feasibility of performing point-of-care ultrasound for splenomegaly by emergency physicians in the emergency department setting.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
October 4, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laurie Robichaud

Laurie Robichaud, MD

Jewish General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 10 and 35 year-old presenting to the ED with suspected acute infectious mononucleosis

Exclusion Criteria

  • Chronic infectious disorders (eg. tuberculosis, malaria, HIV, syphilis)
  • Inflammatory disorders (eg. sarcoidosis, amyloidosis, systemic lupus erythematosus, Felty syndrome)
  • Proliferative disorders (eg. lymphoma, leukemia, essential thrombocytopenia, polycythemia vera)
  • Congestive disorders (eg: cirrhosis, portal hypertension, right heart failure, congenital heart disease)
  • Chronic haemolytic anemia (eg. sickle cell, thalassemia, hereditary spherocytosis)
  • Storage diseases (eg. Gaucher, Niemann-Pick)
  • Splenectomy
  • Inability to give informed consent

Outcomes

Primary Outcomes

Presence of splenomegaly (maximal splenic cranio-caudal length) on point-of-care ultrasound

Time Frame: 12 months

Splenomegaly is defined as a splenic length of \> 11.5 centimetres (cm) for 10-12 year-old patients, \> 12 cm for 12-15 year-old patients, \> 12 cm for 15-35 year-old female patients, and \> 13 cm for 15-35 year-old male patients.

Study Sites (2)

Loading locations...

Similar Trials